On Sept. 15, 2020, Vaxess Technologies and Medigen Vaccine Biologics (MBV) announced a partnership to develop a combined…
On Sept. 15, 2020, Thermo Fisher Scientific announced it was investing more than $140 million to further expand…
On Sept. 15, 2020,Tonix Pharmaceuticals announced that the first patient was enrolled in the observational COV-LOGIC study (TNX-C001),…
On Sept. 15, 2020, OPKO Health announce it had initiated a Phase 2 trial with RAYALDEEﾮ as a…
On Sept. 15, 2020, UT Southwestern research suggested conditions related to obesity, including inflammation and leaky gut, leave…
On Sept. 15, 2020, the University of Texas Health Science Center at Houston (UTHealth) announced that a study…
On Sept. 15, 2020, Novavax announced an amendment to its existing agreement with Serum Institute of India which…
On Sept. 15, 2020, initial findings reported by the Arizona COVID-19 Genomics Union (ACGU) suggested that following Arizona’s…
On Sept. 15, 2020, the NIH awarded seven contracts worth a total of $22.8 million to companies and…
On Sept. 14, 2020, scientists at the Max Planck Institute for Infection Biology in Berlin and the Institut…
On Sept. 14, 2020, the U.S. Department of Defense, on behalf of the Department of Health and Human…
On Sept. 14, 2020, Valneva announced a vaccine partnership with the UK government for its inactivated COVID-19 vaccine,…
On Sept. 14, 2020, Vaxart announced that the FDA had completed its review of the Companyﾒs Investigational New…
On Sept. 14, 2020, Mateon Therapeutics announced that its global study based on its ARTI-19 protocol for Artemisinin…
On Sept. 14, 2020, Illumina announced that the Australian public health laboratories will aim to sequence the virus…
On Sept. 14, 2020, Humanigen and Lonza announced a strategic collaboration to expand the manufacturing capacity for lenzilumab…
On Sept. 14, 2020, Humanigen announced its Phase 3 registration trial of lenzilumab in patients with COVID-19 was…
On Sept. 14, 2020, Eli Lilly and Incyte announced initial data from the Adaptive COVID-19 Treatment Trial (ACTT-2)…
On Sept. 14, 2020, Regeneron and the University of Oxford announced that RECOVERY (Randomised Evaluation of COVid-19 thERapY),…
On Sept. 14, 2020, Meridian Bioscience announced the launch of a novel highly sensitive SARS-CoV-2 antibody pair to…
On Sept. 14, 2020, at the Pacific Northwest National Laboratory (PNNL) reported that U.S. analysts monitoring global biothreats…
On Sept. 12, 2020, Pfizer and BioNTech announced that they had submitted an amended protocol to the FDA…
On Sept. 11, 2020, MediciNova announced development progress on its intranasal SARS-CoV-2 vaccine for COVID-19 utilizing BC-PIV, a…
On Sept. 11, 2020, UC Berkeley School of Public Health researchers reported that probability analysis showed the U.S….
On Sept. 11, 2020, the CDC reported that twelve children acquired COVID-19 in child care facilities. One parent…
On Sept. 10, 2020, the NIH launched two of three adaptive Phase 3 clinical trials evaluating the safety…
On Sept. 10, 2020, Corvus Pharmaceuticals announced updated data from its ongoing Phase 1 study investigating the potential…
On Sept. 9, 2020, Sinovac Biotech announced that the inactivated COVID-19 vaccine candidate developed by Sinovac Life Sciences…
On Sept. 9, 2020, Harvard Medical School investigators at Massachusetts General Hospital reported that patients hospitalized with severe…
On Sept. 9, 2020, Pfizer and BioNTech announced preliminary preclinical data in mouse and non-human primate models from…